Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Genocea Biosciences, Inc. (GNCA)  
$0.59 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 51,640,000
Market Cap: 30.69(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.5943 - $0.5943
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Genocea Biosciences is a biopharmaceutical company that discovers and develops cancer immunotherapies using its proprietary ATLAS™ platform. The ATLAS platform can profile each patient's CD4+ and CD8+ T cell immune responses to every potential target or antigen identified by sequencing of that patient's tumor. GEN-011 is an investigational solid tumor cell therapy candidate comprised of CD4+ and CD8+ neoantigen-targeted peripheral T cells. GEN-011 is comprised of T cells extracted from the patient's peripheral blood and specific for ATLAS-prioritized neoantigens. GEN-009 is an investigational neoantigen vaccine delivering adjuvanted synthetic long peptides from ATLAS-identified neoantigens.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 93,582,981
Total Sell Value $0 $0 $0 $6,768,648
Total People Sold 0 0 0 15
Total Sell Transactions 0 0 0 27
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 182
  Page 2 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sandell Scott D 10% Owner   –       –       •   2022-05-24 4 S $0.07 $387,943 I/I (5,931,843) 4,445,093     -
   Behbahani Ali Director   –       •       •   2022-05-24 4 S $0.07 $387,943 I/I (5,931,843) 4,445,093     -
   Duvall Diantha CHIEF FINANCIAL OFFICER   •       –      –    2022-04-04 4 S $1.25 $1,204 D/D (963) 91,775     -
   Clark William D President and CEO   •       •      –    2022-04-04 4 S $1.25 $4,905 D/D (3,924) 369,487     -
   Flechtner Jessica Baker Chief Scientific Officer   •       –      –    2022-04-04 4 S $1.25 $1,515 D/D (1,212) 96,193     -
   Davis Thomas Andrew CHIEF MEDICAL OFFICER   •       –      –    2022-04-04 4 S $1.25 $1,364 D/D (1,091) 68,330     -
   Aakalu Girish N CHIEF BUSINESS OFFICER   •       –      –    2022-04-04 4 S $1.25 $1,204 D/D (963) 74,459     -
   Clark William D President and CEO   •       •      –    2022-03-16 4 S $1.10 $12,579 D/D (11,435) 373,411     -
   Aakalu Girish N CHIEF BUSINESS OFFICER   •       –      –    2022-03-16 4 S $1.10 $2,637 D/D (2,397) 75,422     -
   Duvall Diantha CHIEF FINANCIAL OFFICER   •       –      –    2022-03-16 4 S $1.10 $3,160 D/D (2,873) 92,738     -
   Flechtner Jessica Baker Chief Scientific Officer   •       –      –    2022-03-16 4 S $1.10 $3,684 D/D (3,349) 97,405     -
   Davis Thomas Andrew CHIEF MEDICAL OFFICER   •       –      –    2022-03-16 4 S $1.10 $2,989 D/D (2,717) 69,421     -
   Stapleton Raymond D Jr CHIEF TECHNOLOGY OFFICER   •       –      –    2022-03-15 4 A $0.00 $0 D/D 43,750 46,250     -
   Sumer Jacquelyn L CHIEF LEGAL & COMPLIANCE OFF   •       –      –    2022-03-15 4 A $0.00 $0 D/D 37,500 45,500     -
   Clark William D President and CEO   •       •      –    2022-03-15 4 A $0.00 $0 D/D 150,000 384,846     -
   Aakalu Girish N CHIEF BUSINESS OFFICER   •       –      –    2022-03-15 4 A $0.00 $0 D/D 31,250 77,819     -
   Duvall Diantha CHIEF FINANCIAL OFFICER   •       –      –    2022-03-15 4 A $0.00 $0 D/D 37,500 95,611     -
   Flechtner Jessica Baker Chief Scientific Officer   •       –      –    2022-03-15 4 A $0.00 $0 D/D 43,750 100,754     -
   Davis Thomas Andrew CHIEF MEDICAL OFFICER   •       –      –    2022-03-15 4 A $0.00 $0 D/D 31,250 72,138     -
   Duvall Diantha CHIEF FINANCIAL OFFICER   •       –      –    2021-03-15 4 A $0.00 $0 D/D 37,500 37,500     -
   Clark William D President and CEO   •       •      –    2021-03-15 4 A $0.00 $0 D/D 150,000 150,000     -
   Davis Thomas Andrew CHIEF MEDICAL OFFICER   •       –      –    2021-03-15 4 A $0.00 $0 D/D 31,250 31,250     -
   Flechtner Jessica Baker Chief Scientific Officer   •       –      –    2021-03-15 4 A $0.00 $0 D/D 43,750 43,750     -
   Aakalu Girish N CHIEF BUSINESS OFFICER   •       –      –    2021-03-15 4 A $0.00 $0 D/D 31,250 31,250     -
   Sumer Jacquelyn L CHIEF LEGAL & COMPLIANCE OFFOf   •       –      –    2021-02-22 3 IO $0.00 $0 D/D 0 5,500     -
  182 Records found
  1  2  3  4  5  6  7  8   
  Page 2 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us